Emory Center for AIDS Research receives $10 million NIH renewal
The Center for AIDS Research at Emory University (CFAR) received a five-year, $10 million award from the National Institutes of Health (NIH) to further its work in decreasing HIV incidence, improving the well-being of infected individuals, training the next generation of researchers and clinical leaders, and ultimately finding a vaccine and cure for HIV.
CFAR at Emory University is co-directed by Carlos del Rio, MD, Hubert Professor and chair of the Department of Global Health at the Rollins School of Public Health, James W. Curran, MD, MPH, the James W. Curran Dean of the Rollins School of Public Health, and Eric Hunter, PhD, Georgia Research Alliance Eminent Scholar and professor of pathology and laboratory medicine at Emory University School of Medicine. For nearly two decades, CFAR has made significant strides in addressing the AIDS epidemic through clinical, basic, and prevention science. Dr. Hunter is also a faculty member in the IMP and MMG programs.
"We are proud of our track record of cultivating and strengthening HIV/AIDS research for the past 18 years,” says Hunter. "Our world-class scientists are making a tremendous impact through their groundbreaking research and collaborative efforts. Through this continuation of NIH funding, we are able to move forward on our mission and intensify our efforts to reach our ultimate goals of developing an effective vaccine and finding a cure for HIV."
Click here to view the full story in the Emory News Center. The story is also featured in the Atlanta Business Chronicle.